A new stage in the fight against cancer may begin in Russian medicine. It is proposed to add innovative cancer vaccines to the draft program of state guarantees for 2026 — technologies that were recently considered the medicine of the future, TASS reports, citing the draft decree.
We are talking about personalized therapy based on mRNA vaccines, the Oncopept peptide vaccine, as well as cellular immunotherapy with genetically modified components. Such drugs are created individually for each patient and actually "train" the immune system to find and destroy tumor cells.
The technologies are being developed by leading scientific centers of the country — the National Research Center for Epidemiology and Microbiology named after N. F. Gamaleya (NRCEM), the National Medical Research Center of Radiology of the Ministry of Health of Russia and the National Medical Research Center of Oncology named after N. N. Blokhin.
If the project is approved, innovative treatments may become part of the free medical care system and make advanced cancer technologies more accessible to thousands of patients.
